Latin America & Caribbean vs Netherlands: Antiretroviral therapy coverage
Latin America & Caribbean
71.6%
in 2024
Netherlands
89.0%
in 2023
Latin America & Caribbean rank
19th
Netherlands rank
21st
Antiretroviral therapy coverage over time
- Latin America & Caribbean
- Netherlands
How they compare
Netherlands currently reports 89.0% against 71.6% in Latin America & Caribbean, a difference of 17.4%.
That makes Netherlands's figure about 1.2 times Latin America & Caribbean's.
Across all 24 years both countries report, Netherlands has been ahead every year.
Latin America & Caribbean ranks 19th and Netherlands ranks 21st of 23 groups.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latin America & Caribbean | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.9% | 53.5% | 32.6% | Netherlands |
| 2010s | 48.7% | 77.2% | 28.5% | Netherlands |
| 2020s | 67.3% | 87.8% | 20.4% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Latin America & Caribbean or Netherlands?
- Netherlands, at 89.0% against 71.6% in Latin America & Caribbean as of 2023.
- What is the difference in antiretroviral therapy coverage between Latin America & Caribbean and Netherlands?
- 17.4%, with Netherlands ahead.
- How many years of comparable data are there for Latin America & Caribbean and Netherlands?
- 24 years are reported by both, from 2000 to 2023.
- How do Latin America & Caribbean and Netherlands rank globally for antiretroviral therapy coverage?
- Latin America & Caribbean ranks 19th and Netherlands ranks 21st of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.